Publications | Venatorx Pharmaceuticals

Publications

Manuscripts

In Vitro Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates of Gram-Negative Bacilli from 2018 to 2020: Results from the Global Evaluation of Antimicrobial Resistance via Surveillance (GEARS) Program

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

MORE MANUSCRIPTS

Conference Presentations

In Vitro Activity of Cefepime-Taniborbactam and Comparators against a Global Collection of Carbapenem-Resistant Enterobacterales (CRE) and Carbapenem-Resistant Pseudomonas aeruginosa (CRPA) with and without Carbapenemases

Activities of Cefepime-Taniborbactam and Ceftazidime-Avibactam against Cefepime-Resistant Respiratory Gram-Negative Pathogens in a Hollow Fiber Infection Model

Development of Cefepime-Taniborbactam MIC Antimicrobial Susceptibility Test for Gram-Negative Bacteria on MicroScan Dried Gram-Negative MIC Panels

Antimicrobial Activity of Cefepime-Taniborbactam and Comparators against Clinical Isolates from ICU and Non-ICU Patients; 2018-2020 Global Surveillance

MORE CONFERENCE PRESENTATIONS